HER2 Targeted Therapy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global HER2 Targeted Therapy Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028.

Human epidermal growth factor receptor 2 (HER2), a member of the human epidermal growth factor receptor family, plays an important role in the development and progression of various types of cancer, particularly breast cancer. Over time, it has emerged as an important target for drug therapy to treat various types of breast cancer. HER2-targeted therapy has emerged as a promising therapeutic option to prevent tumor cells from evading immune surveillance. In 1998, the FDA approved the first HER2-targeting monoclonal antibody, called Herceptin (trastuzumab), for the treatment of metastatic breast cancer.

Market Segments

Based on type

• Monotherapy
• Combination Therapy

Based on application

• Breast Cancer
• Stomach Cancer
• Head and Neck Cancer
• Lung Cancer
• Ovarian Cancer

Key Players

• GlaxoSmithKline
• Bayer
• Abbott
• AbbVie
• Pfizer
• Sanofi
• Agilent
• Glenmark Pharmaceuticals
• Merck
• Roche
• Novartis
• Astra Zeneca

Scope of the Report

The research study analyzes the global HER2 Targeted Therapy industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by HER2 Targeted Therapy Market Report

1. What was the HER2 Targeted Therapy Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of HER2 Targeted Therapy Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the HER2 Targeted Therapy Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.